Skip to main content
Log in

Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

A prospective study was conducted to evaluate azithromycin in combination with pyrimethamine for treatment of acuteToxoplasma encephalitis in patients with AIDS. Of the 14 patients given 75 mg pyrimethamine and 500 mg azithromycin daily for four weeks, eight were evaluable for clinical response. Five responded favorably, one had an intermediate response and two an unfavorable response. Of the nine patients evaluable for radiological response, six responded favorably, and three had an intermediate response. Eleven adverse events occurred in nine patients: rash (n=5), abnormal liver function (n=2), vomiting (n=3) and hypoacousia (n=1). This pilot study suggests that the combination of pyrimethamine and azithromycin may be further investigated and that the optimal dosage of azithromycin has yet to be determined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Luft BJ, Remington JS: Toxoplasmic encephalitis in AIDS. Clinical Infectious Diseases 1992, 15: 211–222.

    PubMed  Google Scholar 

  2. Leport C, Raffi F, Matheron S, Katlama C, Regnier B, Saimot AG, Marche C, Vedrenne C, Vildé JL: Treatment of central nervous system toxoplasmosis with pyrimethamine-sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous treatment. American Journal of Medicine 1988, 84: 94–100.

    Article  PubMed  Google Scholar 

  3. Dannemann B, McCutchan JA, Israelski D, Antoniski D, Leport C, Luft B, Nussbaum J, Clumeck N, Morlat P, Chiu J, Vildé JL, Orellana M, Feigal D, Bertok A, Heseltine P, Leedom J, Remington J, andthe California Collaborative Group: Treatment of toxoplasmic encephalitis in patients with AIDS: a randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfonamides. Annals of Internal Medicine 1992, 116: 33–43.

    PubMed  Google Scholar 

  4. Fernandez-Martin J, Leport C, Morlat P, Meyohas MC, Chauvin JP, Vildé JL: Pyrimethamine-clarithromycin combination for treatment of acuteToxoplasma encephalitis in patients with AIDS. Antimicrobial Agents and Chemotherapy 1991, 35: 2049–2052.

    PubMed  Google Scholar 

  5. Chang HR, Pechere JC: In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) onToxoplasma gondii. Antimicrobial Agents and Chemotherapy 1988, 32: 524–529.

    PubMed  Google Scholar 

  6. Derouin F, Almadany R, Chau F, Rouveix B, Pocidalo JJ: Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis. Antimicrobial Agents and Chemotherapy 1992, 35: 997–1001.

    Google Scholar 

  7. Mertens J, Barneveld P, Asin H, Ligtvoet E, Maarten V, Branger T, Hoepelman A: Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis. Antimicrobial Agents and Chemotherapy 1992, 36: 1456–1459.

    PubMed  Google Scholar 

  8. Remington JS, Vildé JL: Clindamycin forToxoplasma encephalitis in AIDS. Lancet 1991, 338: 1142–1143.

    Article  Google Scholar 

  9. Huskinson-Mark J, Araujo FG, Remington JS: Evaluation of the effect of drugs on the cyst form ofToxoplasma gondii. Journal of Infectious Discases 1991, 164: 170–177.

    Google Scholar 

  10. Gladue RP, Bright GM, Isaascon RE, Newborg MF: In vitro and in vivo uptake of azithromycin (CP-62, 993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrobial Agents and Chemotherapy 1989, 33: 277–282.

    PubMed  Google Scholar 

  11. Israelski D, Dannemann B, Remington JS: Toxoplasmic encephalitis in patients with AIDS. In: Sande MA, Volberding PA (ed): The medical management of AIDS. WB Saunders, Philadelphia, 1990, p. 241–266.

    Google Scholar 

  12. Swanson DJ, Sung Rj, Fine MJ, Orloff JJ: Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia. American Journal of Medicine 1992, 92: 61–68.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saba, J., Morlat, P., Raffi, F. et al. Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. Eur. J. Clin. Microbiol. Infect. Dis. 12, 853–856 (1993). https://doi.org/10.1007/BF02000407

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02000407

Keywords

Navigation